Building AI-Native Biotechnology Companies
How artificial intelligence changes scientific workflows, company structure, organizational leverage, and decision-making.
Attenuated Technologies
Speaking and professional conversations.
Michael Churchill is available for selected panels, interviews, executive discussions, and invited presentations on biotechnology company building, translational strategy, precision medicine, scientific leadership, and AI-enabled organizational workflows.
Topics can be tailored for scientific, executive, investor, founder, and professional audiences.
Areas Michael can discuss
Translational Science as an Organizational Discipline
Why successful translation depends on the integration of discovery, biomarkers, clinical development, operations, and governance.
Building Organizations Around Complex Science
How founders and executives create clarity, accountability, and execution across scientific, technical, clinical, and business teams.
From Scientific Platform to Company Strategy
How technical potential becomes a differentiated company thesis, product strategy, development plan, and organization.
Small Teams and Organizational Leverage
How capable teams, effective systems, and artificial intelligence can outperform larger conventional structures.
Diagnostics, Multimodal Data, and Precision Medicine
How biological, clinical, and computational data can be integrated into clinically useful products.
Appropriate audiences
- Biotechnology founders
- Executive leadership teams
- Scientific organizations
- Investors and boards
- Translational and clinical-development teams
- Technology and artificial-intelligence leaders
- Academic and entrepreneurial communities
Potential formats include
- Keynote or invited presentation
- Executive briefing
- Panel discussion
- Fireside conversation
- Workshop
- Podcast or interview
- Internal company session
- Scientific or strategic retreat
Speaker resources
Speaker materials can be provided for confirmed or prospective engagements.
Discuss a speaking opportunity.
For conferences, panels, interviews, executive sessions, or scientific events, contact Attenuated Technologies with the audience, format, and subject under consideration.